Literature DB >> 11707593

CD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation.

D Kaplan1, D Smith, H Meyerson, N Pecora, K Lewandowska.   

Abstract

Dim expression of CD5 on human B lymphocytes has been used to delineate B1 and B2 subsets. Nevertheless, others have suggested that the molecule is an activation marker and does not predicate a subset distinction. We have used enzymatic amplification staining, a technology that enhances the resolution of flow cytometric analysis of cell surface molecules by as much as 100-fold, to determine that essentially all human B cells express CD5. Furthermore, we show that this expression is regulated during Epstein-Barr virus transformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11707593      PMCID: PMC61130          DOI: 10.1073/pnas.241509398

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Enzymatic amplification staining for flow cytometric analysis of cell surface molecules.

Authors:  D Kaplan; D Smith
Journal:  Cytometry       Date:  2000-05-01

2.  Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.

Authors:  M T Kasaian; H Ikematsu; P Casali
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

3.  CD5 mRNA expression and auto-antibody production in early human B cells immortalized by EBV.

Authors:  T Paavonen; R Quartey-Papafio; P J Delves; L Mackenzie; T Lund; P Youinou; P M Lydyard
Journal:  Scand J Immunol       Date:  1990-03       Impact factor: 3.487

4.  A human CD5+ B cell clone that secretes an idiotype-specific high affinity IgM monoclonal antibody.

Authors:  R W van der Heijden; H Bunschoten; A Hoek; J Van Es; M Punter; A D Osterhaus; F G Uytdehaag
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

5.  'Fetal-type' B and T lymphocytes in rheumatoid arthritis and primary Sjögren's syndrome.

Authors:  C Plater-Zyberk; F M Brennan; M Feldmann; R N Maini
Journal:  J Autoimmun       Date:  1989-06       Impact factor: 7.094

6.  High resolution immunophenotypic analysis of chronic lymphocytic leukemic cells by enzymatic amplification staining.

Authors:  D Kaplan; H Meyerson; K Lewandowska
Journal:  Am J Clin Pathol       Date:  2001-09       Impact factor: 2.493

7.  Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways.

Authors:  Y Z Cong; E Rabin; H H Wortis
Journal:  Int Immunol       Date:  1991-05       Impact factor: 4.823

8.  Rheumatoid factor secretion from human Leu-1+ B cells.

Authors:  R R Hardy; K Hayakawa; M Shimizu; K Yamasaki; T Kishimoto
Journal:  Science       Date:  1987-04-03       Impact factor: 47.728

9.  The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA).

Authors:  R A Miller; J Gralow
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

10.  CD5 maintains tolerance in anergic B cells.

Authors:  K L Hippen; L E Tze; T W Behrens
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

View more
  11 in total

Review 1.  CD5, an important regulator of lymphocyte selection and immune tolerance.

Authors:  Chander Raman
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells.

Authors:  Kwan-Ki Hwang; Xi Chen; Daniel M Kozink; Marietta Gustilo; Dawn J Marshall; John F Whitesides; Hua-Xin Liao; Rosa Catera; Charles C Chu; Xiao-Jie Yan; Micah A Luftig; Barton F Haynes; Nicholas Chiorazzi
Journal:  Blood       Date:  2011-12-12       Impact factor: 22.113

3.  A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease.

Authors:  Davide Bagnara; Matthew S Kaufman; Carlo Calissano; Sonia Marsilio; Piers E M Patten; Rita Simone; Philip Chum; Xiao-Jie Yan; Steven L Allen; Jonathan E Kolitz; Sivasubramanian Baskar; Christoph Rader; Hakan Mellstedt; Hodjattallah Rabbani; Annette Lee; Peter K Gregersen; Kanti R Rai; Nicholas Chiorazzi
Journal:  Blood       Date:  2011-03-08       Impact factor: 22.113

4.  Prognostic information and biological insights in chronic lymphocytic leukemia by high-resolution immunophenotypic analysis of ZAP70.

Authors:  David Kaplan; Zhuoxin Sun; Martin S Tallman; Ian W Flinn; Wenbin Xiao; Paolo F Caimi; Nicholas M Kaye; Hillard M Lazarus
Journal:  Cytometry A       Date:  2014-05-20       Impact factor: 4.355

5.  Tyramide signal amplification for analysis of kinase activity by intracellular flow cytometry.

Authors:  Matthew R Clutter; Garrett C Heffner; Peter O Krutzik; Kacey L Sachen; Garry P Nolan
Journal:  Cytometry A       Date:  2010-11       Impact factor: 4.355

6.  Protein Biomarkers in Monocytes and CD4+ Lymphocytes for Predicting Lithium Treatment Response of Bipolar Disorder: a Feasibility Study with Tyramine-Based Signal-Amplified Flow Cytometry.

Authors:  Keming Gao; Marzieh Ayati; Mehmet Koyuturk; Joseph R Calabrese; Stephen J Ganocy; Nicholas M Kaye; Hillard M Lazarus; Eric Christian; David Kaplan
Journal:  Psychopharmacol Bull       Date:  2022-02-25

7.  Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.

Authors:  A Veronese; F Pepe; J Chiacchia; S Pagotto; P Lanuti; S Veschi; M Di Marco; A D'Argenio; I Innocenti; B Vannata; F Autore; M Marchisio; D Wernicke; F Verginelli; G Leone; L Z Rassenti; T J Kipps; R Mariani-Costantini; L Laurenti; C M Croce; R Visone
Journal:  Leukemia       Date:  2014-04-15       Impact factor: 11.528

8.  Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection.

Authors:  Anders Rosén; Ann-Charlotte Bergh; Peter Gogok; Chamilly Evaldsson; Anna Lanemo Myhrinder; Eva Hellqvist; Abu Rasul; Magnus Björkholm; Mattias Jansson; Larry Mansouri; Anquan Liu; Bin Tean Teh; Richard Rosenquist; Eva Klein
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

9.  De-novo transcriptome sequencing of a normalized cDNA pool from influenza infected ferrets.

Authors:  Jeremy V Camp; Thomas L Svensson; Alexis McBrayer; Colleen B Jonsson; Peter Liljeström; Carl E Bruder
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

10.  Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies.

Authors:  Eric Meffre; Anne Schaefer; Hedda Wardemann; Patrick Wilson; Eric Davis; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2003-12-29       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.